These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 602619)

  • 1. Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease.
    Chainuvati T; Plengvanit U; Viranuvatti V
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):434-9. PubMed ID: 602619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
    Szám I; Szentner J; Hegedüs-Wein I; Vass A; Szilárd T
    Wien Med Wochenschr; 1974 May; 124(20):319-25. PubMed ID: 4829691
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 6. [Critical study of venous blood ammonia in hepatic coma. Diagnosis, surveillance and treatment].
    Dupuy R; Thiroloix J
    Rev Int Hepatol; 1967; 17(1):43-53. PubMed ID: 6060728
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of the arginine-ornithine combination on the arterial ammonia levels in chronic liver diseases and hepatic coma].
    Miszputen SJ; Ganc AJ; Costa AA; Reibscheid S; Vilela MP
    AMB Rev Assoc Med Bras; 1968 Jul; 14(7):117-22. PubMed ID: 5304250
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of ornithine-ketoglutarate on provoked hyperammonaemia in patients with cirrhosis of the liver (author's transl)].
    Blahíková L; Horký J; Pechar J; Vidlaková M; Zvolánková K; Vosmík J; Marecková O
    Cesk Gastroenterol Vyz; 1978 Jun; 32(4):262-7. PubMed ID: 688420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hepatic comas by ornithine alpha-ketoglutarate].
    Tête R; Paliard P; Vachon A
    Rev Lyon Med; 1966 Apr; 15(8):371-8. PubMed ID: 5942225
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension.
    Kundra A; Jain A; Banga A; Bajaj G; Kar P
    Clin Biochem; 2005 Aug; 38(8):696-9. PubMed ID: 15963970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of Ornicetil in psychiatry in cases of alcoholism].
    Grandmontagne O; Portes A; Dupont JM; Durou B
    Ann Med Psychol (Paris); 1969 Jun; 2(1):127-32. PubMed ID: 5376633
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient].
    Michel H; Ogé P; Bertrand L
    Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy.
    Herlong HF; Maddrey WC; Walser M
    Ann Intern Med; 1980 Oct; 93(4):545-50. PubMed ID: 7001971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution to the treatment of portal systemic encephalopathy (author's transl)].
    Blahníková L; Horký J; Pechar J; Honzák R; Vosmík J
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):486-93. PubMed ID: 737756
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of hepatic encephalopathy with Hepa-Mertz].
    Podymova SD; Bueverov AO; Nadinskaia MIu
    Ter Arkh; 1995; 67(6):45-7. PubMed ID: 7667779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Different therapeutic approaches for chronic diffuse liver lesions using ornicetil, lactulose, etimizol and corinfar].
    Neĭko IeM; Mytnyk ZM; Holovach IIu
    Lik Sprava; 2002; (2):64-8. PubMed ID: 12073265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.